Cargando…

Neuroprotective Effects of Shenqi Fuzheng Injection in a Transgenic SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis

Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, in the pathogenesis of which oxidative stress (OS) was believed to play a key role. Shenqi Fuzheng Injection (SFI) concocted from two kinds of Chinese medicinal herbs, Radix Codonopsis and Radix Astragali, wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugimoto, Kazuo, Liu, Jia, Li, MingXuan, Song, YueBo, Zhang, Chi, Zhai, ZhiGuang, Gao, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560685/ https://www.ncbi.nlm.nih.gov/pubmed/34737697 http://dx.doi.org/10.3389/fphar.2021.701886

Ejemplares similares

Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
por: Banerjee, Rebecca, et al.
Publicado: (2008)

Neuroprotective Effect of Bexarotene in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
por: Riancho, Javier, et al.
Publicado: (2015)

Effects of Ovariectomy in an hSOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)
por: Yan, Lina, et al.
Publicado: (2018)

Neuroprotective effect of Shenqi Fuzheng injection pretreatment in aged rats with cerebral ischemia/reperfusion injury
por: Cai, Ying-min, et al.
Publicado: (2016)

Dysregulation of the complement cascade in the hSOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis
por: Lee, John D, et al.
Publicado: (2013)

Molecular Chaperone Mediated Late-Stage Neuroprotection in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
por: Novoselov, Sergey S., et al.
Publicado: (2013)

Cromolyn sodium delays disease onset and is neuroprotective in the SOD1(G93A) Mouse Model of amyotrophic lateral sclerosis
por: Granucci, Eric J., et al.
Publicado: (2019)

Rosmarinic Acid Alleviates Neurological Symptoms in the G93A-SOD1 Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
por: Seo, Ji-Seon, et al.
Publicado: (2015)

Fingerprint analysis of Huolingshengji Formula and its neuroprotective effects in SOD1(G93A) mouse model of amyotrophic lateral sclerosis
por: Zhou, Qinming, et al.
Publicado: (2018)

Optimised and Rapid Pre-clinical Screening in the SOD1(G93A) Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)
por: Mead, Richard J., et al.
Publicado: (2011)

State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model
por: Kim, Renaid B., et al.
Publicado: (2016)

Evaluation of Neuropathological Features in the SOD1-G93A Low Copy Number Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
por: Molnar-Kasza, Agnes, et al.
Publicado: (2021)

Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1(G93A) model of amyotrophic lateral sclerosis
por: Huang, G, et al.
Publicado: (2013)

A comprehensive assessment of the SOD1(G93A) low-copy transgenic mouse, which models human amyotrophic lateral sclerosis
por: Acevedo-Arozena, Abraham, et al.
Publicado: (2011)

Therapeutic effects of hirsutella sinensis on the disease onset and progression of amyotrophic lateral sclerosis in SOD1(G93A) transgenic mouse model
por: Shang, Hai‐Yan, et al.
Publicado: (2019)

Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1(G93A) mice
por: Scaricamazza, Silvia, et al.
Publicado: (2022)

Comparing therapeutic modulators of the SOD1 G93A Amyotrophic Lateral Sclerosis mouse pathophysiology
por: Lee, Albert J. B., et al.
Publicado: (2023)

Lack of Effect of Methylene Blue in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis
por: Lougheed, Rosamond, et al.
Publicado: (2011)

Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis
por: OLIVÁN, Sara, et al.
Publicado: (2014)

Measuring Neuromuscular Junction Functionality in the SOD1(G93A) Animal Model of Amyotrophic Lateral Sclerosis
por: Rizzuto, Emanuele, et al.
Publicado: (2015)

The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice
por: Valsecchi, Valeria, et al.
Publicado: (2020)

MPO/HOCl Facilitates Apoptosis and Ferroptosis in the SOD1(G93A) Motor Neuron of Amyotrophic Lateral Sclerosis
por: Peng, Jialing, et al.
Publicado: (2022)

Targeting autotaxin impacts disease advance in the SOD1‐G93A mouse model of amyotrophic lateral sclerosis
por: Gento‐Caro, Ángela, et al.
Publicado: (2021)

Sex and HDAC4 Differently Affect the Pathophysiology of Amyotrophic Lateral Sclerosis in SOD1-G93A Mice
por: Renzini, Alessandra, et al.
Publicado: (2022)

Shenqi Fuzheng Injection impairs bile duct ligation-induced cholestatic liver injury in vivo
por: Cao, Fei, et al.
Publicado: (2019)

Shenqi Fuzheng Injection in the Treatment of Breast Cancer: A Meta-analysis of Randomized Controlled Trials
por: Liu, Shuyu, et al.
Publicado: (2018)

Shenqi Fuzheng Injection Combined With Chemotherapy for Gastric Cancer: An Overview of Systematic Reviews and Meta-Analyses
por: Xu, Jing, et al.
Publicado: (2023)

SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization
por: Banci, Lucia, et al.
Publicado: (2008)

Metal-deficient SOD1 in amyotrophic lateral sclerosis
por: Hilton, James B., et al.
Publicado: (2015)

Ginseng gintonin alleviates neurological symptoms in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis through lysophosphatidic acid 1 receptor
por: Nam, Sung Min, et al.
Publicado: (2021)

Compensatory Motor Neuron Response to Chromatolysis in the Murine hSOD1(G93A) Model of Amyotrophic Lateral Sclerosis
por: Riancho, Javier, et al.
Publicado: (2014)

Activation of the endoplasmic reticulum stress response in skeletal muscle of G93A*SOD1 amyotrophic lateral sclerosis mice
por: Chen, Dapeng, et al.
Publicado: (2015)

Seeking homeostasis: temporal trends in respiration, oxidation, and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice
por: Irvin, Cameron W., et al.
Publicado: (2015)

Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis
por: Apolloni, Savina, et al.
Publicado: (2017)

Spinal Cord Metabolic Signatures in Models of Fast- and Slow-Progressing SOD1(G93A) Amyotrophic Lateral Sclerosis
por: Valbuena, Gabriel N., et al.
Publicado: (2019)

Argonaute 2 is lost from neuromuscular junctions affected with amyotrophic lateral sclerosis in SOD1(G93A) mice
por: Shapiro, Dillon, et al.
Publicado: (2022)

Caudal–Rostral Progression of Alpha Motoneuron Degeneration in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
por: Kirby, Alastair J., et al.
Publicado: (2022)

Administration of 4-(α-L-Rhamnosyloxy)-benzyl Isothiocyanate Delays Disease Phenotype in SOD1(G93A) Rats: A Transgenic Model of Amyotrophic Lateral Sclerosis
por: Galuppo, Maria, et al.
Publicado: (2015)

Shenqi Fuzheng Injection Combined with Chemotherapy for Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Lv, Yanhong, et al.
Publicado: (2015)

Shenqi Fuzheng Injection Alleviates the Transient Worsening Caused by Steroids Pulse Therapy in Treating Myasthenia Gravis
por: Qi, Guo-Yan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o19h6oco0q9ubn54fdr6099m8l